MARC details
000 -LEADER |
fixed length control field |
03307cam a2200337 a 4500 |
001 - CONTROL NUMBER |
control field |
17709376 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220527085911.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
130422s2014 njua b 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2013016301 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781118148891 (cloth) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(DNLM)101606602 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DNLM/DLC |
Transcribing agency |
DLC |
Modifying agency |
DLC |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RM301.25 |
Item number |
.B57 2014 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 241 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.19 |
Edition number |
22 |
245 00 - TITLE STATEMENT |
Title |
Biological drug products: development and strategies |
Statement of responsibility, etc. |
edited by Wei Wang, Manmohan Singh |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Hoboken, N.J. : |
Name of publisher, distributor, etc. |
Wiley, |
Date of publication, distribution, etc. |
c2014. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xv, 728 p. : |
Other physical details |
ill. ; |
Dimensions |
25 cm. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
An overview of discovery and development process for biologics / Heather H. Shih, Paula Miller, Douglas C. Harnish -- Nonclinical safety assessment of biologics, including vaccines / Liangbiao George Hu, David W. Clarke -- Clinical assessment of biologics agents / Lesley Ann Saketkoo, Shikha Mittoo, Luis R. Espinoza -- Key regulatory guidelines for development of biologics in the U.S. and Europe / Richard Kingham, Gabriela Klasa, Krista Hessler Carver -- Landscape and consideration of intellectual property for development of biosimilars / Srikumaran Melethil -- Scientific aspects of sterility assurance, sterility, asepsis, and sterilization / James E. Akers and James P. Agalloco -- Cell cell culture processes in monoclonal antibody production / Feng Li, Amy (Yijuan) Shen, Ashraf Amanullah -- Protein/peptide purification and virus reduction / Beckley K. Nfor, Esteban Freydell, and Marcel Ottens -- Chemical and genetic modification / M Farys ... [et al.] -- Analytical characterization of proteins/peptides / Yajun Jennifer Wang and Brian Hosken -- Protein/peptide formulation development / Satoshi Ohtake and Wei Wang -- Regulatory strategies and lessons in the development of biosimilars / Umang S. Shah -- Vaccine development : history, current status, and future trends / Leo Van Der Pol, Jean-Pierre Amorij -- Role and application of adjuvants and delivery systems in vaccines / Rajesh K. Gupta -- Methods for characterizing proteins in aluminum adjuvant formulations / Martinus A.H. Capelle, Emilie Poirier, Tudor Arvinte -- The state of the art and future of gene medicines / Frank Jacobs, Stephanie C. Gordts, Bart De Geest -- Nucleic acid vaccines / Rachel Buglione-Corbett ... [et al.] -- Multifunctional polymeric nano-systems for RNA interference therapy / Arun Iyer ... [et al.] -- Advent and maturation of regenerative medicine / Abner M. Mhashilkar, Anthony Atala -- Conventional and novel container closure/delivery systems / Joseph Wong, Mahesh V. Chaubal -- Controlled-release systems for biologics / Mayura Oak ... [et al.] -- Routes of delivery for biological drug products / Darrell J. Irvine, Xingfang Su, Brandon Kwong. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Biological Agents |
General subdivision |
pharmacology. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Biological Agents |
General subdivision |
therapeutic use. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug Delivery Systems. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug Discovery. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Wang, Wei, |
Dates associated with a name |
1957 March 10- |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Manmohan Singh, |
Dates associated with a name |
1964 November 8- |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Online version: |
Title |
Biological drug products |
Place, publisher, and date of publication |
Hoboken, N.J. : John Wiley & Sons, c2014 |
International Standard Book Number |
9781118695036 |
Record control number |
(DLC) 2013016910 |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
a |
7 |
b |
cbc |
c |
orignew |
d |
1 |
e |
ecip |
f |
20 |
g |
y-gencatlg |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Books |